Skip to main content

Abbvie M13-596 A Single-Arm, Open-Label, Multicenter Study to Evaluate the Safety and Efficacy of ABT-493/ABT-530 in Adult Post-Liver or Post-Renal Transplant Recipients with Chronic Hepatitis C Virus Genotype 1 - 6 Infection (MAGELLAN-2)

Clinical Trial Grant
Duke Scholars

Administered By

Medicine, Gastroenterology

Awarded By

AbbVie Inc.

Start Date

April 1, 2016

End Date

February 11, 2019
 

Administered By

Medicine, Gastroenterology

Awarded By

AbbVie Inc.

Start Date

April 1, 2016

End Date

February 11, 2019